select trial glp 1 GLP-1 medications are not just for weight loss — they are the most important drug class of our lifetime. 🫀 A 2025 meta-analysis of 99,599 patients confirmed: ✓ 20% reduction in major GLP-1 receptor agonists (GLP-1RAs): cardiovascular

This remarkable glucose-dependent property of GLP-1 action results in a situation in which intravenously administered GLP-1 fails to reduce levels of blood glucose below fasting levels

Long-term benefits, on the other hand, include: Enhanced Memory: Regular administration can help maintain cognitive function over time

They tracked cardiovascular events, blood clots, healthcare utilization, and death

Tuy nhin, vic s dng liu cao cn tun th ng hng dn ca sn phm hoc c s t vn t bc s chuyn khoa trnh tc dng ph khng mong mun

GLP-1 receptor agonists represent a significant advancement in metabolic health, with emerging evidence suggesting they may actually support kidney function rather than harm it